Purilogics is currently developing a novel and first-in-market high-capacity, -selectivity, and -throughput affinity membrane for the purification of mRNA…

A key focus of Purilogics is to emphasize the drastic decrease in processing time when using our membranes for biologics purification…

At Purilogics, we take pride in designing and developing membrane chromatography technologies for biologics purification. Our mission is to provide rapid and effective purification solutions to help the biopharmaceutical industry simplify biologics purification.

Purilogics®’ PurexaTM-MQ multimodal anion-exchange chromatography membrane is differentiated by its high binding capacity and effectiveness in removing impurities such as host cell proteins, virus particles, DNA, and aggregates from biologic products under conditions of high solution conductivity…